Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)

Clinical trial NCT01065766 · COMPLETED

Trial details

NCT number: NCT01065766
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus

Start date: 2009-03-01
Primary completion: 2013-05-01
Enrollment: 4065

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.